TT - EU to require additional cancer risk labeling on CAR T therapies
2024-06-14 15:55:36 ET
More on Bristol-Myers Squibb Company , Gilead Sciences, etc.
- Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least
- Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Bristol-Myers Squibb: Could This Be A Value Trap? (Technical Analysis)
- Gilead spikes as Jefferies highlights weight loss prospects
- Bristol Myers gets FDA approval for Autyro for NTRK-positive cancers